Article | August 13, 2020

Ahead Of The Curve: Pharma Preparing For A Post COVID-19 World

By Bobby Sheng

proactive-planning

‘Business Preparedness’ is a term rarely used outside the boardroom, but in light of the COVID-19 crisis, it’s gaining new relevance. Currently, it’s on everyone’s agenda and at the forefront of most internal meetings.

Pharma has had to react and respond very quickly, in order to manage the pandemic’s potential impact, which has led many to immediately set into motion a series of initiatives to ensure that we responded effectively.

Global problem, global response

Pharma and government agencies are responding around the world, working vigorously on a number of fronts to combat the virus. Taiwan, for example, has been recognized in the media for its efforts to help stop the disease on both social and scientific fronts.

As a global pharmaceutical developer and contract manufacturing supply chain partner in Taiwan, we’ve yet to experience any significant impact from the pandemic and we may owe much of it to our country’s vigorous response. From a business preparedness standpoint globally, we acted swiftly and secured all our facilities in a similar manner.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: